Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Summary

This is a randomized, parallel, open-label study of patients who have responded to treatment in the acute phase of their manic or mixed episode, with or without psychotic symptoms, with olanzapine in mono or co-therapy, and who are in syndromic and symptomatic remission at the time of enrollment into the study.

Timeline

Start

2004-10

Primary completion

—

Completion

2006-03

Drugs

Indications